Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

8,028

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

December 31, 2008

Study Completion Date

June 30, 2016

Conditions
Breast Cancer
Interventions
DRUG

letrozole

Letrozole 2.5 mg daily oral administration.

DRUG

tamoxifen citrate

Tamoxifen 20 mg daily oral administration.

Trial Locations (3)

2100

Rigshospitalet, Copenhagen

33076

Institut Bergonie, Bordeaux

CH-9007

Kantonsspital - St. Gallen, Sankt Gallen

All Listed Sponsors
collaborator

UNICANCER

OTHER

collaborator

Danish Breast Cancer Cooperative Group

OTHER

lead

ETOP IBCSG Partners Foundation

NETWORK

NCT00004205 - Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer | Biotech Hunter | Biotech Hunter